Company intelligence / Profile preview

POLYSAN

Saint Petersburg, Saint Petersburg, Russiapolysan.cz ↗

Ownership: Private
Development stage: Commercial

Overview

POLYSAN is a leading Russian pharmaceutical company with several original drugs on the market, including Cycloferon (an immunomodulator/antiviral), Reamberin (a succinic acid-based infusion for detoxification), and Cytoflavin (a metabolic agent). The company has a strong R&D focus with 8 new products reportedly in development. Its products are registered in Russia and exported to 17 countries. Clinical results for marketed drugs have led to their inclusion in federal treatment standards for various infectious diseases[1][2][5].

Therapeutic areas: OtherInfectious Diseases
Modalities: Small moleculeBiologic (for some products)
Industry: Biotech

Drug pipeline

7 assets

arginine sodium succinate

Approved

6 more assets in the full pipeline.

Request access →

Partnerships

Bayer AG (strategic partnership for contract manufacturing of Bayer’s Ultravist® at POLYSAN facilities)Pfizer Inc. (production agreement for three Pfizer pharmaceutical products at POLYSAN facilities)

Beyond the preview

Go deeper on POLYSAN.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on POLYSAN.

Explore the full profile